Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

FDA announces recall of cryoablation catheters after multiple injuries, including 4 deaths
Boston Scientific is recalling the catheters associated with its POLARx Cryoablation System due to a heightened risk of esophageal injury. The FDA has ruled that this a Class I recall.
Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker
The first-in-human procedures were performed in Prague with the investigational Aveir CSP leadless pacemaker system.
President of medical device company resigns over conduct allegations after 7 months in role
Joseph C. Wright, a longtime Merit Medical employee, resigned after unspecified allegations regarding his conduct were brought to light. He was named the company's new president back in May.
FDA and Boston Scientific issue urgent alert about pacemaker failures following 2 deaths
The U.S. Food and Drug Administration issued the recall notice for more than 200,000 pacemakers because a battery issue could lock the device in safe mode.
Treating AFib patients with TAVR still linked to elevated risks
While the technology and techniques associated with TAVR have advanced over the years, treating patients who present with baseline atrial fibrillation is still associated with certain risks.

Medtronic shared new STROKE AF data on the Reveal Linq ICM

Medtronic ICM a cost-effective approach for reducing the risk of ischemic stroke

Remote monitoring with the Reveal Linq insertable cardiac monitor can improve outcomes without breaking the bank, according to new data being presented at the International Stroke Conference in Phoenix.

February 7, 2024

Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston,

Biosense Webster shares latest data on its pulsed field ablation system

The company, part of Johnson & Johnson MedTech, shared positive data from two different clinical trials at AF Symposium 2024 in Boston.

February 5, 2024

Targeting the left atrial posterior wall during pulsed field ablation fails to improve outcomes

Researchers explored the potential of an alternate way to perform PFA on patients with persistent AFib, presenting their findings live at AF Symposium 2024 in Boston.

February 2, 2024

Medtronic's PulseSelect Pulse Field Ablation (PFA) System

Real-world patients now being treated with Medtronic’s PFA system

Medtronic is celebrating the success of its PulseSelect pulsed field ablation product by highlighting its impact on heart patients around the world.

February 1, 2024

Farapulse Boston Scientific Pulsed Field Ablation PFA fda approval

FDA approves Boston Scientific’s pulsed field ablation system for AFib

The FDA’s final decision was based largely on positive results from the ADVENT clinical trial, which compared treatment with the Farapulse PFA System to the current standard of care.

January 31, 2024

Esolution device S4 Medical PFA ablation esophagus

New medical device helps cardiologists limit esophageal injuries during RF ablation procedures

Injuries to the esophagus remain a common complication associated with radiofrequency ablation procedures. New research suggests a device developed by S4 Medical could significantly reduce the risk of such injuries.

January 30, 2024

Element Science Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)

New patch-based wearable defibrillator receives CE mark approval

The device, which also received Great Britain’s UKCA marking, was specifically designed to be less bulky and easier to wear than other wearable cardioverter-defibrillators.

January 26, 2024

Medicare data stethoscope healthcare trends graphs finance financials

An updated look at combining LAAO with ablation, TAVR or other interventional heart procedures

Performing two procedures at once does not appear to make a significant impact on patient safety, though it may lead to a few new risks sure to interest heart teams.

January 23, 2024

Electrophysiology

FDA announces recall of cryoablation catheters after multiple injuries, including 4 deaths

Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker

President of medical device company resigns over conduct allegations after 7 months in role

FDA and Boston Scientific issue urgent alert about pacemaker failures following 2 deaths

Treating AFib patients with TAVR still linked to elevated risks